Effects of successful parathyroidectomy on metabolic cardiovascular risk factors in patients with severe primary hyperparathyroidism

Endocrine Practice

Volumn 17, Issue 4, 2011, Pages 584-590

  Ishay, Avraham ^a,b   Herer, Paula ^a   Luboshitzky, Rafael ^a,b  

^a HAEMEK MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; GLUCOSE; INSULIN; LIPID; PARATHYROID HORMONE; URIC ACID;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BONE DENSITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM;

ADULT; BLOOD GLUCOSE; CALCIUM; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; INSULIN; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROIDECTOMY; RISK FACTORS; URIC ACID;

EID: 84860389450     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP10321.OR     Document Type: Article

References (30)

1. Lundgren E, Lind L, Palmér M, Jakobsson S, Ljunghall S, Rastad J. Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years. Surgery. 2001;130:978-985. (Pubitemid 34014563)
2. Headbäck G, Odén A. Increased risk of death from primary hyperparathyroidism-an update. Eur J Clin Invest. 1998;28:271-276.
3. Raue F. Increased incidence of cardiovascular diseases in primary hyperparathyroidism - a cause for more aggressive treatment? Eur J Clin Invest. 1998;28:277-278.
4. Bergenfelz A, Bladström A, Their M, Nordenström E, Valdemarsson S, Westerdhal J. Serum levels of uric acid and diabetes mellitus infuence survival after surgery for primary hyperparathyroidism: a prospective cohort study. World J Surg. 2007;31:1393-1400. (Pubitemid 46945380)
5. Neunteuf T, Heher S, Prager G, et al. Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcemia: results of a 3-year follow-up study. Clin Endocrinol (Oxf). 2000;53:229-233. (Pubitemid 30643458)
6. Garcia de la Torre N, Wass JA, Turner HE. Parathyroid adenomas and cardiovascular risk. Endocr Relat Cancer. 2003;10:309-322. (Pubitemid 36758657)
7. Luboshitzky R, Chertok-Schaham Y, Lavi I, Ishay A. Cardiovascular risk factors in primary hyperparathyroid-ism. J Endocrinol Invest. 2009;32:317-321.
8. Nilsson IL, Aberg J, Rastad J, Lind L. Maintained normalization of cardiovascular dysfunction 5 years after para-thyroidectomy in primary hyperparathyroidism. Surgery. 2005;137:632-638. (Pubitemid 40755420)
9. Hagström E, Lundgren E, Lithell H, et al. Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over fve years. Clin Endocrinol (Oxf). 2002;56:253-260. (Pubitemid 34233964)
10. Khaleeli AA, Johnson JN, Taylor WH. Prevalence of glucose intolerance in primary hyperparathyroidism and the beneft of parathyroidectomy. Diabetes Metab Res Rev. 2007;23:43-48. (Pubitemid 46152485)
11. Sancho JJ, Rouco J, Riera-Vidal R, Sitges-Serra A. Long-term effects of parathyroidectomy for primary hyper-parathyroidism on arterial hypertension. World J Surg. 1992;16:732-735.
12. Bollerslev J, Rosen T, Mollerup CL, et al (SIPH Study Group). Effects of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2009;94:2255-2261.
13. Bilzekian JP, Potts JT Jr, Fuleihan Gel-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87:5353-5361. (Pubitemid 36034328)
14. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientifc statement; executive summary. Crit Pathw Cardiol. 2005;4:198-203. (Pubitemid 41697502)
15. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487-1495. (Pubitemid 38680001)
16. Norman J, Goodman A, Politz D. Calcium, parathyroid hormone, and vitamin D in patients with primary hyper-parathyroidism: normograms developed from 10,000 cases. Endocr Pract. 2011;17:384-394.
17. Ogard CG, Engelmann MD, Kistorp C, Nielsen SL, Vestergaard H. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of infammation related to atherosclerosis in patients with primary hyperparathyroid-ism. Clin Endocrinol (Oxf). 2005;63:493-498. (Pubitemid 41626742)
18. Walker MD, Silverberg SJ. Cardiovascular aspects of primary hyperparathyroidism. J Endocrinol Invest. 2008;31: 925-931.
19. Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease-a review. Eur Heart J. 2004;25:1776-1787. (Pubitemid 39330228)
20. Bolland MJ, Grey AB, Gamble GD, Reid IR. Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab. 2005;90:1525-1530. (Pubitemid 40464014)
21. Feldstein CA, Akopian M, Pietrobelli D, Olivieri A, Garrido D. Long-term effects of parathyroidectomy on hypertension prevalence and circadian blood pressure pro-fle in primary hyperparathyroidism. Clin Exp Hypertens. 2010;32:154-158.
22. Rydberg E, Birgander M, Bondeson AG, Bondeson L, Willenheimer R. Effects of successful parathyroidectomy on 24-hour ambulatory blood pressure in patients with primary hyperparathyroidism. Int J Cardiol. 2010;142:15-21.
23. Valdemarsson S, Lindblom P, Bergenfelz A. Metabolic abnormalities related to cardiovascular risk in primary hyperparathyroidism: effect of surgical treatment. J Intern Med. 1998;244:241-249. (Pubitemid 28389661)
24. Lind L, Jacobsson S, Palmér M, Lithell H, Wengle B, Ljunghall S. Cardiovascular risk factors in primary hyper-parathyroidism: a 15-year follow-up of operated and unop-erated cases. J Intern Med. 1991;230:29-35.
25. Grey A, Reid I. Body weight and bone mineral density in primary hyperparathyroidism. Ann Intern Med. 1995;123:732.
26. Westerdahl J, Valdemarsson S, Lindblom P, Bergenfelz A. Urate and arteriosclerosis in primary hyperparathyroid-ism. Clin Endocrinol (Oxf). 2001;54:805-811.
27. Duh QY, Morris RC, Arnaud CD, Clark OH. Decrease in serum uric acid level following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg. 1986;10:729-736. (Pubitemid 16096434)
28. Hamerman D. Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies. QJM. 2005;98:467-484. (Pubitemid 41430104)
29. Burnett JR, Vasikaran SD. Cardiovascular disease and osteoporosis: is there a link between lipids and bone? Ann Clin Biochem. 2002;39(pt 3):203-210. (Pubitemid 34494209)
30. Silverberg SJ, Locker FG, Bilezikian JP. Vertebral osteo-penia: a new indication for surgery in primary hyperpara-thyroidism. J Clin Endocrinol Metab. 1996;81:4007-4012. (Pubitemid 26380410)